87 related articles for article (PubMed ID: 27729374)
21. Proto-oncogene Src links lipogenesis via lipin-1 to breast cancer malignancy.
Song L; Liu Z; Hu HH; Yang Y; Li TY; Lin ZZ; Ye J; Chen J; Huang X; Liu DT; Zhou J; Shi Y; Zhao H; Xie C; Chen L; Song E; Lin SY; Lin SC
Nat Commun; 2020 Nov; 11(1):5842. PubMed ID: 33203880
[TBL] [Abstract][Full Text] [Related]
22. HDAC7-mediated control of tumour microenvironment maintains proliferative and stemness competence of human mammary epithelial cells.
Cutano V; Di Giorgio E; Minisini M; Picco R; Dalla E; Brancolini C
Mol Oncol; 2019 Aug; 13(8):1651-1668. PubMed ID: 31081251
[TBL] [Abstract][Full Text] [Related]
23. Stromelysin-3 over-expression enhances tumourigenesis in MCF-7 and MDA-MB-231 breast cancer cell lines: involvement of the IGF-1 signalling pathway.
Kasper G; Reule M; Tschirschmann M; Dankert N; Stout-Weider K; Lauster R; Schrock E; Mennerich D; Duda GN; Lehmann KE
BMC Cancer; 2007 Jan; 7():12. PubMed ID: 17233884
[TBL] [Abstract][Full Text] [Related]
24. The reciprocal stability of FOXO1 and IRS2 creates a regulatory circuit that controls insulin signaling.
Guo S; Dunn SL; White MF
Mol Endocrinol; 2006 Dec; 20(12):3389-99. PubMed ID: 16916938
[TBL] [Abstract][Full Text] [Related]
25. Transforming potential of alternatively spliced variants of fibroblast growth factor receptor 2 in human mammary epithelial cells.
Moffa AB; Tannheimer SL; Ethier SP
Mol Cancer Res; 2004 Nov; 2(11):643-52. PubMed ID: 15561780
[TBL] [Abstract][Full Text] [Related]
26. Novel insulin receptor substrate 1 and 2 variants in breast and colorectal cancer.
Esposito DL; Verginelli F; Toracchio S; Mammarella S; De Lellis L; Vanni C; Russo A; Mariani-Costantini R; Cama A
Oncol Rep; 2013 Oct; 30(4):1553-60. PubMed ID: 23877285
[TBL] [Abstract][Full Text] [Related]
27. IL-33-Induced Transcriptional Activation of LPIN1 Accelerates Breast Tumorigenesis.
Kim JY; Kim G; Lim SC; Choi HS
Cancers (Basel); 2021 Apr; 13(9):. PubMed ID: 33946554
[TBL] [Abstract][Full Text] [Related]
28. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
[TBL] [Abstract][Full Text] [Related]
29. ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress.
Assaily W; Rubinger DA; Wheaton K; Lin Y; Ma W; Xuan W; Brown-Endres L; Tsuchihara K; Mak TW; Benchimol S
Mol Cell; 2011 Nov; 44(3):491-501. PubMed ID: 22055193
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-22 promotes epithelial cell transformation and breast tumorigenesis via MAP3K8 activation.
Kim K; Kim G; Kim JY; Yun HJ; Lim SC; Choi HS
Carcinogenesis; 2014 Jun; 35(6):1352-61. PubMed ID: 24517997
[TBL] [Abstract][Full Text] [Related]
31. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation.
Gual P; Le Marchand-Brustel Y; Tanti JF
Biochimie; 2005 Jan; 87(1):99-109. PubMed ID: 15733744
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-584 suppresses the progression of ovarian cancer by negatively regulating LPIN1.
Yang L; Ma HL
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1062-1071. PubMed ID: 32096176
[TBL] [Abstract][Full Text] [Related]
33. Type I insulin-like growth factor receptor over-expression induces proliferation and anti-apoptotic signaling in a three-dimensional culture model of breast epithelial cells.
Yanochko GM; Eckhart W
Breast Cancer Res; 2006; 8(2):R18. PubMed ID: 16584539
[TBL] [Abstract][Full Text] [Related]
34. Knockdown of insulin receptor substrate 1 reduces proliferation and downregulates Akt/mTOR and MAPK pathways in K562 cells.
Machado-Neto JA; Favaro P; Lazarini M; Costa FF; Olalla Saad ST; Traina F
Biochim Biophys Acta; 2011 Aug; 1813(8):1404-11. PubMed ID: 21569802
[TBL] [Abstract][Full Text] [Related]
35. Lipin-1 regulates cancer cell phenotype and is a potential target to potentiate rapamycin treatment.
Brohée L; Demine S; Willems J; Arnould T; Colige AC; Deroanne CF
Oncotarget; 2015 May; 6(13):11264-80. PubMed ID: 25834103
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-33/ST2 axis promotes epithelial cell transformation and breast tumorigenesis via upregulation of COT activity.
Kim JY; Lim SC; Kim G; Yun HJ; Ahn SG; Choi HS
Oncogene; 2015 Sep; 34(38):4928-38. PubMed ID: 25531326
[TBL] [Abstract][Full Text] [Related]
37. The ETS transcription factor ESE-1 transforms MCF-12A human mammary epithelial cells via a novel cytoplasmic mechanism.
Prescott JD; Koto KS; Singh M; Gutierrez-Hartmann A
Mol Cell Biol; 2004 Jun; 24(12):5548-64. PubMed ID: 15169914
[TBL] [Abstract][Full Text] [Related]
38. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
Hao L; ElShamy WM
Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
[TBL] [Abstract][Full Text] [Related]
39. Rosiglitazone, an agonist of peroxisome-proliferator-activated receptor gamma (PPARgamma), decreases inhibitory serine phosphorylation of IRS1 in vitro and in vivo.
Jiang G; Dallas-Yang Q; Biswas S; Li Z; Zhang BB
Biochem J; 2004 Jan; 377(Pt 2):339-46. PubMed ID: 14556646
[TBL] [Abstract][Full Text] [Related]
40. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
